BMS tops list of sustainability stars

Four pharmaceutical companies have exceeded the 50 percent mark in an analysis of the voluntary sustainability reporting. Bristol-Myers Squibb, Sanofi-Aventis, Abbott Labs and Johnson & Johnson took top honors among Fortune 500 pharmaceutical companies.

Lowest scores went to Forest Labs, NBTY and King Pharmaceuticals. The analysis was done by the Roberts Environmental Center (REC) at Claremont McKenna College.

The analysis combines environmental and social reports under the heading of sustainability. The top scorers, according to the report, provide extensive reports and Internet pages detailing the company's impact, vision, programs and goals. Those with the lowest scores rarely mention corporate responsibility.

The pharma industry, like most others, did the least reporting on environmental performance.

- here's the report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.